AZEVAN PHARMACEUTICALS, INC.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 31, 2017 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 112 Total Citation Count
- Oct 11, 2002 Earliest Filing
- 5 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9802925 Compositions and methods for treating neurodegenerative diseasesMar 27, 15Oct 31, 17[A61K, C07D]
9597314 Beta-lactamylalkanoic acids for treating premenstrual disordersMar 21, 06Mar 21, 17[A61K, A01N]
8426400 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonistsOct 31, 11Apr 23, 13[A61K, C07D, A61P]
8048874 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonistsJul 18, 06Nov 01, 11[A61K, C07D, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0016,274 BETA-LACTAM CANNABINOID RECEPTOR MODULATORSAbandonedSep 14, 07Jan 21, 10[A61K, C07D, A61P]
2008/0113,959 {Beta}-Lactamyl vasopression V1a antagonists and methods of useAbandonedOct 17, 07May 15, 08[A61K, A61P]
2008/0090,797 {Beta}-Lactamyl vasopression V1a antagonists and methods of useAbandonedOct 17, 07Apr 17, 08[A61K, C07D]
2006/0281,728 3-Substituted beta-lactamyl vasopressin v1a antagonistsAbandonedOct 01, 04Dec 14, 06[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
